Register
Login:
Share:
Email Facebook Twitter


London South East - Oil & Gas Investor Evening: Malcy, Echo, Savannah, SDX
Paul Welch speaks at London South East's Oil & Gas Investor Evening


Summit Ther Share Price (SUMM)



Share Price Information for Summit Ther (SUMM)


Share Price: 29.50Bid: 28.00Ask: 31.00Change: 0.00 (0.00%)No Movement on Summit Ther
Spread: 3.00Spread as %: 10.71%Open: 29.50High: 29.50Low: 28.00Yesterday’s Close: 29.50

Summit Therapeutics Plc Ord 1P

Summit Ther is listed in the FTSE AIM All-Share
Summit Ther is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
29.50
Share Price SpacerBid
28.00
Share Price SpacerAsk
31.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
23,035
Share Price SpacerOpen
29.50
Share Price SpacerHigh
29.50
Share Price SpacerLow
28.00
Share Price SpacerClose
29.50
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 82.13m £24.23m 1,500

52 Week High 242.50 52 Week High Date 25-JAN-2018
52 Week Low 27.00 52 Week Low Date 17-OCT-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
2 14,035 9,000 -2.682 -11.00 0.00 0.00


London South East Users info for Summit Ther




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

19-Oct-18
13:08:24
30.00
9,000
Buy* 
28.00
31.00
2,700
Trade Type:
Ordinary

19-Oct-18
09:52:07
28.50
14,035
Sell* 
28.00
31.00
4,000
Trade Type:
Ordinary

18-Oct-18
16:27:53
29.00
1,000
Sell* 
28.00
31.00
290.00
Trade Type:
Ordinary




View more Summit Ther trades >>

Directors Deals for Summit Ther (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
18-Jul-18Transfer From
Trade Notifier Information for Summit Therapeutics
Frank Armstrong held the position of Non-Executive Chairman at Summit Therapeutics at the time of this trade.
 Frank Armstrong
041,09680538
18-Jul-18Transfer From
Trade Notifier Information for Summit Therapeutics
Barry Price held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Barry Price
019,179116539
18-Jul-18Transfer From
Trade Notifier Information for Summit Therapeutics
Prof Stephen Davies held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Prof Stephen Davies
019,179621660
View more Summit Ther directors dealings >>


Chrisatrdg
Posts: 1,339
Opinion:Strong Buy
Price:29.50
RE: New Summit tweet
Thu 21:25
Hi stew200 - The only thing that will move the SP is positive news i.e. further progress on its Discuva platform etc but for me starting Phase 3 C-Diff next year is the likely time for a SP increase in the meanwhile I expect the SP to remain at the current lowly SP.I do believe that we will be back to £1 next year not sure when.
stew200
Posts: 10,625
Opinion:No Opinion
Price:29.50
New Summit tweet
Thu 20:52
What do you reckon it will actually take for this stock to go up?
Chrisatrdg
Posts: 1,339
Opinion:Strong Buy
Price:29.50
New Summit tweet.
Thu 11:41
Per football from the other board:
Summit Therapeutics‏
Watch @summitplc CMO Dr David Roblin in the @BIA_UK video campaign raising awareness about the real and current threat posed by infectious diseases and antimicrobial resistance
https://www.youtube.com/watch?v=v8ChvMwbbJQ worth watching ;)
stew200
Posts: 10,625
Opinion:No Opinion
Price:30.00
Trading below cash
Mon 11:20
Can’t believe there are sellers here
ilmington
Posts: 8
Opinion:Buy
Price:30.00
RNS
13 Oct '18
Thanks Chris. I didn't spot the reduction in NXDs in an RNS.
View more share chat for Summit Ther (SUMM) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.